Home > Boards > US OTC > Medical - Healthcare > Guided Therapeutics Inc. (GTHP)

There was one surprise, for me anyway, on

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
GetSeriousOK Member Profile
Member Level 
Followed By 20
Posts 2,905
Boards Moderated 0
Alias Born 09/06/14
160x600 placeholder
GetSeriousOK Member Level  Thursday, 05/09/19 06:35:22 PM
Re: Lwe6638 post# 13100
Post # of 13170 
There was one surprise, for me anyway, on page 50, regarding the $1 million worth of stock issuable to SMI in return for their initial $1 million up-front payment:
Quote:
These shares have not been issued as of December 31, 2018.


Two other 10-K tidbits that I actually think might be mistakes -- sheesh, get your stories straight, Gene:

1. the 10-K says the CFDA still has not determined whether the device is Class II or Class III. (Gene said in his April 2 2019 PR "The Chinese FDA has determined that LuViva is a Class 2 medical device.")

2. The 10-K says that as of Dec 31 2018, SMI had paid only $750,000 of the initial $1 million payment. (Gene said in his Nov. 13 2018 PR "Shandong completed the last of its $1 million dollars in payments to Guided Therapeutics under the terms of the agreement between the two companies.")



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist